Form 4: Myriad Genetics SVP Margaret Ancona Reports Stock Disposals for Tax Obligations

Margaret Ancona, SVP and Chief of Staff at Myriad Genetics, reports disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 22, 2025, Margaret Ancona, SVP, Chief of Staff of Myriad Genetics, disposed of 718 shares of common stock at a price of $10.01.
• These shares were withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units.
• An additional 1,904 shares were disposed of at the same price ($10.01) for tax obligations related to performance-based restricted stock units.
• Following these transactions, Ancona beneficially owns 128,684 shares of Myriad Genetics common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock disposals for tax purposes, which is neither particularly positive nor negative.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This filing indicates routine tax-related stock disposals, which are common among executives receiving stock-based compensation.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on shareholders, as they are related to tax obligations and represent a small percentage of the total outstanding shares.

Key Dates

Keywords

Form 4, Myriad Genetics, Stock Disposal, Tax Withholding, Margaret Ancona, Restricted Stock Units, Beneficial Ownership